Compare Kymera Therapeutics Inc. Common Stock (KYMR) vs Verizon Communications Inc (VZ) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Kymera Therapeutics Inc. Common Stock vs Verizon Communications Inc — how do they compare? Kymera Therapeutics Inc. Common Stock trades at $106.9 (market cap $8.87B), while Verizon Communications Inc trades at $44.67 (market cap $180.86B). The key difference: Verizon Communications Inc is far larger — about 20.4× Kymera Therapeutics Inc. Common Stock's market cap, and Verizon Communications Inc pays a 6.5% dividend while Kymera Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Kymera Therapeutics Inc. Common Stock for 0 Days and Verizon Communications Inc for 109 Days on average.
| KYMR | VZ | |
|---|---|---|
Market Cap | $8.87B | $180.86B |
Volume | 779,107 | 30,427,702 |
Sector | Health | Media |
52-Week High | $127.31 | $51.45 |
52-Week Low | $55.80 | $38.40 |
Typical Hold Time | 0 Days | 109 Days |
Enterprise Value | $8.26B | $367.56B |
Dividend Yield | — | 6.5% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Verizon (VZ) trades at $44.42, up 3.83% today, with a bearish technical signal but strong fundamentals including a P/E of 11.34 and a 15.63% ROE. The company has beaten earnings estimates for three consecutive quarters, with Q3 2026 results due October 26, 2026. Recent news highlights its joint venture with AT&T and T-Mobile to expand satellite connectivity and a steady dividend of $0.71 payable November 2, 2026.
The outlook is mixed: low valuation and consistent cash flow support income appeal, but technical weakness and modest revenue growth pose near-term risks. Analyst consensus leans hold with a $47.83 price target, suggesting limited upside. Key risks include competitive pressures and high debt levels, though strong operational cash flow provides stability.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Kymera Therapeutics Inc. Common Stock
Kymera Therapeutics, Inc. is a biopharmaceutical company developing small-molecule medicines based on targeted protein degradation, using its Pegasus platform to direct the body's natural protein-disposal system against disease-causing proteins.
Read more on KYMR →About Verizon Communications Inc
Verizon Communications Inc. is an integrated telecommunications company that provides wire line voice and data services, wireless services, Internet services, and published directory information. The Company also provides network services for the federal government including business phone lines, data services, telecommunications equipment, and payphones.
Read more on VZ →
